Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Pacira BioSciences Inc. total liabilities for the quarter ending December 31, 2025 were 571.8M, a 26.23% decrease year-over-year.
- Pacira BioSciences Inc. total liabilities for 2025 were 571.8M, a 26.23% decrease from 2024.
- Pacira BioSciences Inc. total liabilities for 2024 were 775.2M, a 10.07% increase from 2023.
- Pacira BioSciences Inc. total liabilities for 2023 were 704.3M, a 22.28% decrease from 2022.
- Pacira BioSciences Inc. total liabilities for 2022 were 906.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pacira BioSciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $572 |
| 2024 | $775 |
| 2023 | $704 |
| 2022 | $906 |
| 2021 | $1,345 |
| 2020 | $655 |
| 2019 | $476 |
| 2018 | $368 |
| 2017 | $349 |
| 2016 | $172 |
| 2015 | $169 |
| 2014 | $155 |
| 2013 | $129 |
| 2012 | $46 |
| 2011 | $65 |
| Pacira BioSciences Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $572 |
| 2024-12-31 | $775 |
| 2023-12-31 | $704 |
| 2022-12-31 | $906 |
| 2021-12-31 | $1,345 |
| 2020-12-31 | $655 |
| 2019-12-31 | $476 |
| 2018-12-31 | $368 |
| 2017-12-31 | $349 |
| 2016-12-31 | $172 |
| 2015-12-31 | $169 |
| 2014-12-31 | $155 |
| 2013-12-31 | $129 |
| 2012-12-31 | $46 |
| 2011-12-31 | $65 |
| 2010-12-31 | $115 |
Pacira BioSciences Inc. Total Liabilities — FAQ
Pacira BioSciences Inc. (PCRX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's total liabilities history?
The chart and table above show Pacira BioSciences Inc.'s total liabilities by year and by quarter, including the growth rate.